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Abstract
Background:  Supernumerary marker chromosomes (SMCs) are structurally abnormal extra
chromosomes that cannot be unambiguously identified by conventional banding techniques. In the
past, SMCs have been characterized using a variety of different molecular cytogenetic techniques.
Although these techniques can sometimes identify the chromosome of origin of SMCs, they are
cumbersome to perform and are not available in many clinical cytogenetic laboratories.
Furthermore, they cannot precisely determine the region or breakpoints of the chromosome(s)
involved. In this study, we describe four patients who possess one or more SMCs (a total of eight
SMCs in all four patients) that were characterized by microarray comparative genomic
hybridization (array CGH).
Results: In at least one SMC from all four patients, array CGH uncovered unexpected complexity,
in the form of complex rearrangements, that could have gone undetected using other molecular
cytogenetic techniques. Although array CGH accurately defined the chromosome content of all but
two minute SMCs, fluorescence in situ hybridization was necessary to determine the structure of
the markers.
Conclusion: The increasing use of array CGH in clinical cytogenetic laboratories will provide an
efficient method for more comprehensive characterization of SMCs. Improved SMC
characterization, facilitated by array CGH, will allow for more accurate SMC/phenotype
correlation.
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Background
Supernumerary marker chromosomes (SMCs) are struc-
turally abnormal extra chromosomes that cannot be
unambiguously identified by conventional banding tech-
niques. A comprehensive description of SMCs can provide
valuable information for genetic counseling, yet their
extreme heterogeneity in size, structure, and chromo-
somal origin has resulted in limited characterization of
many markers in clinical laboratories. In the case of SMCs
containing satellites, targeted fluorescent in situ hybridiza-
tion (FISH) testing for the most likely candidates, such as
the inv dup(15q) and the inv dup(22q), are often
employed; however, in the absence of an initial positive
result, subsequent FISH analysis using individual probes
becomes inefficient and costly. Furthermore, SMCs that
lack satellites may have gone unclassified in many labora-
tories in the past.
A variety of molecular cytogenetic techniques that provide
more comprehensive analysis in a single or a few experi-
ments have been described for SMC characterization.
Twenty-four color FISH, multicolor banding, centromere-
specific multicolor FISH (cenM-FISH), subcentromere-
specific multicolor FISH (subcenM-FISH), and microdis-
section followed by reverse FISH may all provide identifi-
cation of the chromosome of origin of SMCs [1-4], but
many of these techniques are not utilized by or accessible
to most clinical laboratories. Even if 24-color FISH is read-
ily available, this technique can result in ambiguous clas-
sification or misclassification of SMCs, particularly if they
are small. In addition, these multicolor FISH techniques
cannot precisely determine the chromosome regions or
breakpoints involved.
Microarray-based comparative genomic hybridization
(array CGH) is an efficient and sensitive technique for
detecting genome-wide copy number alterations at high
resolution [5]. We describe four patients who possess one
or more SMCs (a total of eight SMCs in all four patients)
that were characterized using a combination of G-banded
analysis, FISH, and array CGH. Array CGH not only iden-
tified the chromosome of origin of all but two minute
SMCs, but it also defined the region(s) and breakpoints of
each chromosome involved. In addition, array CGH
revealed unexpected structural SMC complexity that could
easily have been missed if FISH and G-banding alone had
been used for characterization.
Results (summarized in Table 1)
Patient 1
This male with wide-spaced nipples, unilateral cryp-
torchidism, small penis, right clubfoot and left congenital
vertical talus had a peripheral blood chromosome analy-
sis performed shortly after birth. Examination of 35 cells
demonstrated a normal 46,XY karyotype. He was again
evaluated at 14 months of age with findings that also
included developmental delay, mild arthrogryposis, skin
hyperpigmentation distributed along the lines of Blas-
chko, a sacral dimple, and an undescended testis on the
right. Cranial MRI was normal, but lumbar spine MRI
showed cord tethering with hydrosyringomyelia, anterior
wedging of the T2 vertebral body, and incomplete closure
of the L5 and S1 posterior vertebral elements. A scrotal
skin biopsy taken at the time of orchiopexy was submitted
for cytogenetic analysis. Eight of 37 cells were found to
contain a large SMC. Array CGH using an expanded cov-
erage microarray (see Methods) detected low-level gain of
100 BAC clones from 3q22.3 through 3qter (Fig. 1A).
FISH performed on previously G-banded slides using
Table 1: Summary of supernumerary marker chromosomes
Patient 1 Karyotype 46,XY (lymphocytes)
47,XY,+mar [8]/46,XY [29] (fibroblasts)
Array result arr cgh 3q22.3q29(RP11-306L14→RP11-159K3)x2~3
FISH result ish der(3)(q22.3qter)(wcp3+,D3Z1-,RP11-184L10-,RP11-976K13++,RP11-702G16++,qter++)
SMC configuration inv dup(3) (qter→q26→neo→q26→q22.3::q22.3→qter)
Patient 2 Karyotype 48,XY,+mar1,+mar2
Array result arr cgh 13q12.11(RP11-301J16,RP11-408E5,RP11-385E5)x3,13q33.3q34(RP11-54H7→RP11-569D9)x3
FISH result ish der(13)(p12qter)(NOR+,D13Z1/D21Z1+,RP11-347L8+,RP11-408E5+,RP11-63L17+)
SMC configuration 13qter→q33.3::p12→q12.12:
Patient 3 Karyotype 47,XX,+mar
Array result arr cgh 22q11.1q11.21(RP11-701M12→CTD-2593O4)x3,22q13.31q13.33(RP11-281J5→GS1-99K24)x3
FISH result ish der(22)(q11.1qter)(RP11-1037C4+,CTD-2593O4+,RP11-676E13+)
SMC configuration 22pter→q11.21::q13.31→qter
Patient 4 Karyotype 50,XX,+mar1,+mar2,+mar3,+mar4
Array result arr cgh 1p12(RP11-828N6→RP4-794L19)x3,4q12(RP11-39D6→RP11-231C18)x3,7p11.1(RP11-
1324A7)x3,11q11q12.1(RP11-176J24→RP11-624G17)x3
FISH result ish der(X)(p11.1q11.1)(DXZ1+),der(1)(p12)(RP11-527D19+),der(7)(p11.1)(RP11-
1324A7+),der(11)r(4;11)(::11q11→11q12.1::4q12::) (D4Z1-,RP11-601I15+,wcp11+,D11Z1+)
SMC configuration mar1 = der(11)r(4;11)(::11q11→11q12.1::4q12::) mar2 = der(7)(:p11.1:) mar3 = der(1)(:p12:) mar4 = 
der(X)(:p11.1q11.1:)Molecular Cytogenetics 2008, 1:7 http://www.molecularcytogenetics.org/content/1/1/7
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multiple probes from the region of gain confirmed that
the marker was derived from the long arm of chromo-
some 3, and illustrated that the marker had the configura-
tion of an inverted, duplicated 3q (Fig. 1B–D). Also
consistent with the array CGH results that the gain did not
extend more centromeric than 3q22.3, the marker had no
Characterization of inv dup(3q) by array CGH and FISH Figure 1
Characterization of inv dup(3q) by array CGH and FISH. A. Chromosome 3 array CGH plot. The X axis represents 
distal p arm to distal q arm (left to right), with the centromere designated by the vertical dotted line. The blue line is a plot of 
the results from an experiment of Cy5 labeled reference/Cy3 labeled patient, while the pink line is from a dye-reversal experi-
ment (Cy5 patient/Cy3 reference). Slight separation of the plots from q22.3 to qter indicates low-level gain of this region due 
to marker mosaicism. B. Marker chromosome (arrow) and normal chromosome 3 homologues (arrowheads) from the same 
metaphase cell that was initially G-banded (left panel), then destained for FISH analyses (middle and right panels). The middle 
panel shows results of FISH using BAC RP11-976K13 from 3q25.32 (orange signal) and a chromosome 3 alpha satellite probe 
(green). Alpha satellite signal is present on the two normal homologues of chromosome 3, but absent from the inv dup(3q). 
The inv dup(3q) shows two sets of signals from BAC RP11-976K13. The right panel shows results of rehybridization using a 
subtelomeric probe mixture for chromosome 3 (red signal – 3q subtelomeric probe; green signal – 3p subtelomeric probe). 
Note the 3q subtelomeric signals at both ends of the inv dup(3q). C. Whole chromosome 3 paint probe, confirming that the 
marker consists entirely of chromosome 3 material (arrow). D. G-banded image of the inv dup(3q), with the corresponding 
ideogram to the right.
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detectable chromosome 3 alpha satellite DNA by FISH
(Fig. 1B). Although we cannot absolutely exclude the pos-
sibility that the marker contains centromeric material
from another chromosome, no other gains were detected
by array CGH, and G-banded analysis showed a promi-
nent constriction at one end of the marker at band q26,
indicating the likely presence of a neocentromere in that
location. The combined results of G-banded analysis,
array CGH, and FISH were most consistent with the fol-
lowing configuration of the marker: inv
dup(3)(qter→q26→neo→q26→q22.3::q22.3→qter).
Parental chromosome analyses were not performed.
Patient 2
A peripheral blood karyotype was performed on a 2 year-
old male with moderate global developmental delay and
bilateral anterior segment dysgenesis of the eye in the
form of the Axenfeld-Rieger anomaly. In addition, he had
macrocephaly, a past history of bilateral inguinal hernias,
and several depigmented macules. An MRI was significant
for a short, thick corpus callosum, prominent perivascular
spaces with thinning of the gray matter, and an enlarged
posterior fossa. All 20 cells examined from peripheral
blood demonstrated a 48,XY,+mar1,+mar2 karyotype (Fig
2A). The larger marker was approximately one-half the
size of a G-group chromosome, and G-banded analysis
suggested the presence of satellites. The second marker
consisted of a minute fragment. Array CGH using a peri-
centromeric microarray (see Methods) detected a single-
copy gain of 20 BAC clones (approximately 5.3 Mb) from
the pericentromeric region of the long arm of chromo-
some 13 (data not shown). Additional analysis using a
targeted microarray (see Methods) revealed not only a
gain of the pericentromeric region of chromosome 13, but
also single copy gain of approximately 5.5 Mb from the
subtelomeric region of chromosome 13 (13q33.3 to q34)
(Fig. 2B). The intervening region of chromosome 13 cov-
ered by this array (13q14.2 to 13q33.1) did not show
copy number alterations (Fig. 2B). FISH using probes
from both the proximal (RP11-408E5, 13q12.11 and
RP11-347L8, 13q12.13) and distal (RP11-63L17, 13q34)
regions of 13q gain confirmed the origin of the larger SMC
(Fig. 2C and 2D). Both BACs from proximal 13q hybrid-
ized to one arm of the larger SMC, whereas the 13q34 sub-
SMCs from patient 2 Figure 2
SMCs from patient 2. A. G-banded normal chromosome 13 homologues and SMCs (arrows). B. Array CGH plot showing 
gains of both proximal and distal 13q, with normal copy number in between. C. FISH using BACs RP11-408E5 from 13q12.11 
(red signal) and RP11-63L17 from 13q34 (green signal) shows signal from both BACs on the large SMC (arrow), as well as both 
normal homologues of chromosome 13 (arrowheads). D. FISH using BACs RP11-347L8 from 13q12.13 (red signal) and RP11-
63L17 (green) again confirms the presence of both proximal and distal 13q in the large SMC (arrow).
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telomeric BAC probe hybridized to the opposite arm of
the larger SMC. FISH using a probe from the nucleolar
organizing region (NOR) hybridized within the middle of
the larger SMC, apparently flanked by the 13q proximal
long arm segment on one side and by the 13q telomeric
segment on the other side (data not shown). Additional
FISH using a centromere probe for chromosomes 13 and
21 (D13Z1/D21Z1) showed hybridization only to the
larger SMC (data not shown). Thus, none of the probes
showed hybridization to the minute SMC, and its origin
remains unknown. Based on the combined results of array
CGH and FISH, the larger SMC appears to have the fol-
lowing configuration: 13qter→q33.3::p12→q12.12:.
Analysis of 60 peripheral blood metaphase cells from
both parents did not show either of the SMCs.
Patient 3
A peripheral blood karyotype from this term newborn
female with low birthweight, hydrocephalus, possible
partial agenesis of the corpus callosum, preauricular pits,
and total anomalous pulmonary venous return showed a
small mono-satellited SMC in all 20 metaphase cells
examined (Fig. 3A). Array CGH using the pericentromeric
microarray detected a single-copy gain of approximately
3.8 Mb of the proximal long arm of chromosome 22 from
q11.1 to q11.21 (data not shown), including the VCFS/
DiGeorge syndrome critical region (DGS1). Additional
analysis using the expanded coverage microarray revealed
not only the gain of proximal 22q, but also single-copy
gain of approximately 5.2 Mb from 22q13.31 to 22q13.33
(Fig. 3B). The intervening region of chromosome 22, from
q11.21 to q13.31, showed no copy number alterations.
FISH using BAC clones from both the proximal (RP11-
1037C4, 22q11.1 and CTD-2593O4, 22q11.21) and dis-
tal (RP11-676E13, 22q13.33) regions of 22q gain con-
firmed the array findings (Fig. 3C and 3D). Both probes
hybridized to the marker in all 60 cells examined. Thus,
the most likely configuration of this SMC is:
Chromosome 22 SMC from patient 3 Figure 3
Chromosome 22 SMC from patient 3. A. G-banded normal chromosome 22 homologues and SMC (arrow). B. Array 
CGH plot showing gains of both proximal and distal 22q, but not the intervening region between 22q11.21 and q13.31. C. FISH 
using BACs RP11-1037C4 from 22q11.1 (red signal) and RP11-676E13 from 22q13.33 (green signal) shows signal from both 
BACs on the SMC (arrow), as well as both normal homologues on chromosome 22 (arrowheads). D. FISH using BACs CTD-
2593O4 from 22q11.21 (red) and RP11-676E13 (green) again confirms the presence of both proximal and distal 22q in the 
SMC (arrow).
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22pter→q11.21::q13.31→qter. Parental chromosome
analyses were not performed.
Patient 4
A prenatal ultrasound performed on this female fetus
revealed bilateral cleft lip anomaly, ventriculomegaly, and
possible agenesis of the corpus callosum. A 48,XX,+2mar/
49,XX+3mar karyotype was found at amniocentesis per-
formed at another institution. Interphase FISH to screen
for aneuploidies of chromosomes 13, 18, 21, X, and Y
showed three X chromosome centromere signals in 40 out
of 50 nuclei scored, suggesting that one of the marker
chromosomes was derived from the X chromosome. At
birth, bilateral cleft lip anomaly, a flattened nasal profile
(nasomaxillary hypoplasia), and upslanting palpebral fis-
sures were noted. MRI of the brain showed fusion of the
frontal lobes and thalami, as well as partial agenesis of the
corpus callosum, consistent with a semilobar holoprosen-
cephaly. No renal anomalies were detected by ultrasound.
An echocardiogram showed normal intracardiac structure
with a patent ductus arteriosus. A peripheral blood karyo-
type confirmed the amniocentesis finding of multiple
marker chromosomes, but showed four SMCs in the
majority of 20 cells examined. A few cells possibly con-
tained five SMCs, although the minute size of some of the
markers made them difficult to distinguish from debris.
The SMCs ranged in size from minute to one that was
approximately one-third the size of a G-group chromo-
some, and had the appearance of a ring in some cells.
Array CGH using the targeted microarray demonstrated
gains of the pericentromeric regions of 1p, 4q, 7p, and
11q (Fig. 4A). Numbering of the SMCs from 1 to 4, with
SMC 1 representing the largest, and SMC 4 representing
the smallest, SMC 1 hybridized with both a chromosome
11 centromere probe (D11Z1) and BAC RP11-601I15
from 4q12 (Fig. 4B), but did not hybridize with a chromo-
some 4 alpha satellite probe (not shown). SMC 2 hybrid-
ized with BAC RP11-1324A7 from 7p11.1 (Fig. 4C), while
SMC3 hybridized with BAC RP11-527D19 from 1p12
(Fig. 4D). SMC 4 hybridized with an X chromosome cen-
tromere probe (DXZ1) as expected based on the results
from amniocentesis. X chromosome alpha satellite
sequence is not represented on the targeted microarray
that was used for array CGH, and the X chromosome did
not show any obvious gains, suggesting that this marker
may contain only X centromere material, or a very limited
amount of euchromatin. Thus, combined array CGH and
FISH results revealed the following configurations of the
SMCs in this patient:
SMC1: der(11)r(4;11)(::11q11→11q12.1::4q12::)
SMC2: der(7)(:p11.1:)
SMC3: der(1)(:p12:)
SMC4: der(X)(:p11.1q11.1:)
SKY was also performed by an independent laboratory.
Results from five cells, each containing two to three SMCs,
showed tentative assignments from chromosomes 1, 5, 7,
11, and 16 (data not shown). FISH did not confirm the
presence of chromosome 5 or 16 material in the SMCs.
Thus, although SKY classified SMCs derived from chro-
mosomes 1, 7, and 11 material, it did not detect chromo-
some 4 material in the der(11) SMC, and SMCs in two
cells were incorrectly identified as derived from chromo-
somes 5 and 16. Parental karyotypes were normal.
Discussion
Identification of chromosome of origin of SMCs by array 
CGH
Characterization of the SMCs in this study was performed
using either a combination of a pericentromeric microar-
ray and a microarray targeted to specific clinically-relevant
regions, or a microarray with expanded coverage. The
expanded coverage microarray combines all of the cover-
age of the first two chips, in addition to having expanded
clone coverage within and between known microdeleton/
microduplication critical regions. Array CGH was able to
identify the chromosome of origin of all but two of the
eight SMCs in the four patients who were studied. In one
patient (patient 2) who demonstrated two SMCs, array
CGH correctly identified the larger of the two markers as
a chromosome 13 SMC. FISH using a number of probes
from both proximal and distal 13q, including a 13/21
centromere probe, showed hybridization to the larger of
the two SMCs only. The second SMC in this patient was
minute (see Fig. 2A). In our experience, markers of this
size typically fail to show hybridization using 24-color
FISH, or yield ambiguous results that are not confirmed
with subsequent whole chromosome paints or centro-
mere probes. The X chromosome SMC from patient 4 (see
Fig. 4E) that was not identified by array CGH or by SKY
was also minute, and may be entirely composed of X cen-
tromere material.
Unexpected structural complexity of SMCs revealed by 
array CGH
In addition to correctly classifying the chromosomal ori-
gin of all but two minute SMCs, array CGH uncovered
complex SMC rearrangements that could have been
missed if FISH alone had been used for characterization.
The chromosome 13 SMC in patient 2 was shown to con-
tain discontinuous segments of proximal and distal 13q
by array CGH. FISH using a 13/21 centromere probe,
although positive in this SMC, would not have distin-
guished between these two chromosomes, and it would
not have given any information with respect to the regions
of chromosome 13 contained within the marker. Twenty-
four color FISH might have been able to classify the chro-Molecular Cytogenetics 2008, 1:7 http://www.molecularcytogenetics.org/content/1/1/7
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Characterization of multiple marker chromosomes in patient 4 by array CGH and FISH Figure 4
Characterization of multiple marker chromosomes in patient 4 by array CGH and FISH. A. Chromosome plots 
showing pericentromeric gains of 1p, 4q, 7p, and 11q detected by array CGH. B. – D. G-banded and corresponding destained 
FISH images of the marker chromosomes. B. FISH using BAC RP11-601I15 from 4q12 (orange) and a chromosome 11 alpha 
satellite probe (green), demonstrating the presence of both chromosome 11 centromere and 4q12 material in the largest SMC 
(arrow). One normal homologue of chromosome 11 (white arrowhead) and one normal homologue of chromosome 4 (gray 
arrowhead) are also shown. C. FISH using BAC RP11-1324A7 from 7p11.1, demonstrating signal on a marker chromosome 
(arrow) and one of the normal chromosome 7 homologues (arrowhead). D. FISH using BAC RP11-527D19 from 1p12, dem-
onstrating signal on a marker chromosome (arrow) and one of the normal chromosome 1 homologues (arrowhead). E. FISH 
using an X alpha satellite probe (green) and a probe containing the steroid sulfatase (STS) gene (orange). The smallest marker 
chromosome contains X centromere material, but not STS (arrow). One normal X chromosome homologue is also shown 
(arrowhead).Molecular Cytogenetics 2008, 1:7 http://www.molecularcytogenetics.org/content/1/1/7
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mosome of origin of this SMC, but it would also not have
revealed the discontinuous nature of the chromosome 13
content. An analogous situation was seen with the chro-
mosome 22 SMC (patient 3) that contains discontinuous
segments from 22q. Interestingly, in a recent study of
twenty-six patients with nonsatellited SMCs characterized
by array CGH, only one was found to have this type of
SMC complexity [6]. The analphoid SMC derived from 3q
could have been classified using 24-color FISH; however,
this technique would not have indicated the region of
chromosome 3 involved. A multicolor centromere-spe-
cific technique would also not have been able to classify
this SMC because of the absence of a conventional chro-
mosome 3 centromere. SKY performed on patient 4, who
had multiple SMCs in every cell, resulted in some errone-
ous chromosome classifications and failed to identify
chromosome 4 material in one SMC.
Utility of FISH for complete SMC characterization
Although array CGH accurately identified the chromo-
some content of most of the SMCs in the patients pre-
sented here, FISH was necessary to determine the structure
of the markers. Array CGH correctly defined the segment
of 3q comprising the analphoid SMC in patient 1, but
FISH ultimately characterized the inverted, duplicated
configuration of this marker. By array CGH, the SMC in
patient 2 was known to contain discontinuous segments
of chromosome 13, but the complex structure of the
marker, consisting of short arm material flanked on both
sides by different segments of long arm material, was only
revealed by FISH. Patients 1 and 4 illustrate the utility of
performing FISH on previously G-banded slides.
Although array CGH correctly detected extra material
from both chromosomes 4 and 11 in patient 4 who had
multiple SMCs per cell, FISH after G-banding was neces-
sary to demonstrate that the largest SMC was composed of
material from both of these chromosomes. FISH of previ-
ously G-banded cells also helped characterize the inv
dup(3q) that was present in only approximately 20 per-
cent of metaphase cells, allowing for targeted analysis of
cells known to contain the marker.
SMCs and phenotype
Although the focus of this study was not to perform an
extensive phenotype/SMC correlation, array CGH ena-
bled a more accurate correlation.
Patient 1: Neocentric chromosome 3 SMC
There are at least eight previously reported SMCs that con-
sist of a neocentric inv dup(3q). Seven of these cases had
breakpoints that were substantially more distal (q26, q27,
or q28) to the q22.3 breakpoint seen in the patient pre-
sented here (reviewed in [7]). The inv dup(3q) was
mosaic in all but one case, and had severe clinical effects
in all patients. In addition to these seven patients, there
was a recent report of a patient with an analphoid, inv
dup(3q) and a breakpoint also present in q22.3 [8]. This
patient shares some clinical features with the patient pre-
sented here and others who have duplications of 3q,
including genital abnormalities and various defects in clo-
sure of the vertebral column and neural tube. Both
patients also exhibited developmental delay and hyper-
pigmentation along the lines of Blaschko, although the
latter finding is not uncommon in patients with chromo-
somal mosaicism.
Patient 2: SMC derived from chromosome 13
For many previously reported acrocentric SMCs that were
positive by FISH using a D13Z1/D21Z1 probe, the origin
of the SMC from chromosome 13 versus chromosome 21
was not determined, confounding phenotypic correlation
with these markers. One of the distinctive findings in
patient 2 was that of Axenfeld-Rieger anomaly. Mutations
in PITX2 (4q25) and FOXC1 (6p25), as well as cytoge-
netic abnormalities involving these loci, have been found
in a wide variety of phenotypes that share features with
Axenfeld-Rieger anomaly [9,10]. Axenfeld-Rieger anom-
aly has also been linked to a third locus at 13q14 [9]. This
locus may be contained within the SMC found in patient
2, as there is a gap in clone coverage in this region on the
targeted array. It is unclear how an additional copy of this
locus would cause the phenotype; however, ocular abnor-
malities, including anterior chamber anomalies, have
been described in patients with trisomy 13 [11].
Patient 3: SMC derived from chromosome 22
A disproportionate number of SMCs are derived from
chromosome 22, and these SMCs vary greatly in structure,
22q content, and phenotypic effect [12]. A subset of chro-
mosome 22 SMCs are associated with cat eye syndrome.
These SMCs are bisatellited and contain proximal 22q
material, with breakpoints either at the proximal or the
distal end of the 22q11 deletion syndrome (DiGeorge/
Velocardiofacial syndrome) critical region [13]. The cat
eye syndrome phenotype is highly variable and does not
correlate with morphology or size of the bisatellited 22q
SMC. The chromosome 22 SMC reported here in patient
3 was not bisatellited, and contained not only proximal
22q material including the DiGeorge/VCFS critical region,
but also distal 22q, from q13.31 to qter. The phenotypic
findings in patient 3 have been described in some patients
with trisomy 22/mosaic trisomy 22, although patients
with trisomy 22 have multiple additional abnormalities
not seen in patient 3. The findings in patient 3 that have
been described in trisomy 22 include hydrocephalus,
preauricular pits, and heart defects including anomalous
venous return [14,15]. Congenital hydrocephalus and
hypoplasia of the corpus callosum have also been
reported in patients with duplication of 22q13.1 to qter,
and 22q13.2 to qter, respectively [16].Molecular Cytogenetics 2008, 1:7 http://www.molecularcytogenetics.org/content/1/1/7
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Patient 4: Multiple SMCs in the same patient
Patient 4 presented with an abnormal phenotype consist-
ing of semilobar holoprosencephaly and bilateral cleft lip,
but no other major malformations. This patient was
found to have up to four different SMCs in every cell.
Whereas a few SMCs have been associated with specific
phenotypes, correlation of SMCs with phenotype is prob-
lematic due to differences in chromosome of origin,
mosaicism, amount of euchromatic material present in
the SMC, and the possibility of uniparental disomy of the
two normal chromosome homologues. Phenotype/geno-
type correlations in patients with multiple SMCs may be
further complicated by different combinations of SMCs in
different cells. Approximately 25–50% of patients with
holoprosencephaly have a numerical or structural chro-
mosome abnormality [17]. Trisomy 13 is a frequent
numerical abnormality, and structural abnormalities
involving almost every chromosome have been reported
in these patients [17]. In one study of holoprosencephaly,
all of the cytogenetically abnormal patients had malfor-
mations in other organ systems in addition to craniofacial
malformations, and two-thirds had malformations in
three or more organ systems [18]. The absence of addi-
tional malformations in this patient with multiple SMCs
suggests that these markers do not contain a significant
amount of euchromatin.
Mechanism of formation of SMCs
Neocentric chromosome 3 SMC
Although neocentromeres derived from almost all human
chromosomes have been reported, hotspots of formation
seem to exist [19,20]. The long arm of chromosome 3 is
one region that is disproportionately represented amongst
neocentromeres [20]. The most common configuration of
neocentric chromosomes, including those involving 3q, is
that of a supernumerary inverted duplication of the distal
arm of a chromosome [7,20]. A frequently proposed
mechanism for formation of these markers is that of a U-
type exchange between homologous chromosomes dur-
ing meiosis [21,20]; however, DNA polymorphism stud-
ies indicate that neocentric SMCs can form either during
meiosis or mitosis [22,23,8].
SMCs composed of discontinuous segments of the same 
chromosome
Two of the markers described in this study fall into this
category. We speculated that the most likely configuration
of the SMC 13 was: 13qter→q33.3::p12→q12.12. Alterna-
tively, if the marker had the configuration:
13q33.3→qter::p12→q12.12, then this marker may have
initially been a ring, and then lost the interstitial segment
of 13q, between q12 and q33. It is difficult to distinguish
between the two configurations, given the very distal
breakpoint in 13q33.
Multiple SMCs in the same patient
There are numerous reports of patients with multiple
SMCs, particulary multiple ring chromosomes [24,21,25].
Daniel and Malafiej (2003) hypothesized that these addi-
tional markers could arise from a superfluous haploid
pronucleus in which there is incomplete digestion of
some chromosomes, and transfection of these leftover
pieces into the zygote [24]. The high proportion of cases
with multiple SMCs that are almost always of different
centromeric origin is consistent with this hypothesis.
Conclusion
Based on the different types of SMCs presented here, array
CGH is the best initial technique for characterization of
these abnormal chromosomes, followed by FISH for com-
plete elucidation of marker structure. We and others have
found that array CGH using a chip that not only has good
pericentromeric coverage, but also adequate overall
genome coverage, is necessary for complete SMC charac-
terization [6,26]. Improved SMC characterization, facili-
tated by array CGH, will allow for more accurate SMC/
phenotype correlation in the future. More accurate geno-
type/phenotype correlation has also been recently
reported for ring chromosomes characterized by array
CGH in patients who have a 46 chromosome count [27].
Although array CGH using chips that provide comprehen-
sive genome coverage may become the technology of
choice for initial characterization of SMCs, G-banded and
FISH analyses are still indispensable for determining the
structure and level of mosaicism of these chromosomes.
G-banded analysis may also be useful for detecting low-
level mosaic SMCs that could potentially be missed by
array CGH.
Methods
SMCs
SMCs were originally identified by conventional cytoge-
netic analysis performed in the Children's Hospital and
Regional Medical Center Cytogenetics Laboratory. Array
CGH was subsequently requested by the referring pro-
vider to characterize the markers further. Approval for this
study was given by the Seattle Children's Hospital
Research Institute Institutional Review Board (application
#X-07-047).
Array CGH
Array CGH on all of the cases was performed using arrays
developed and manufactured at Signature Genomic Labo-
ratories, LLC (Spokane, WA). One or more of the follow-
ing arrays was used in each case: 1) a high-density
pericentromeric microarray with coverage of all 43 unique
human pericentromeric regions (Signature MarkerChip™
Version 1.0 [28]); 2) a targeted microarray (Signature-
Chip® Version 4.0 [29,30]; and 3) an expanded coverage
microarray (SignatureChip WG™ Version 1.0) [31]. Isola-Molecular Cytogenetics 2008, 1:7 http://www.molecularcytogenetics.org/content/1/1/7
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tion and labeling of DNA, microarray hybridization, and
microarray analysis were performed as described previ-
ously [28].
FISH
All abnormalities detected by array CGH were confirmed
and visualized by metaphase or interphase FISH using
one or more BAC clones determined to be abnormal by
array CGH [32]. In some cases, FISH using commercially
available probes (Abbott Molecular Inc., Des Plaines, IL or
Cytocell Technologies, Cambridge, U.K.) was also per-
formed with the ThermoBrite denaturation/hybridization
system according to the manufacturer's procedure (Abbott
Molecular Inc.). For FISH after G-banding, oil was
removed by soaking slides in fresh xylene substitute
(Thermo Fisher Scientific, Waltham, MA) for 12 minutes.
The slides were then placed in methanol for 12 minutes,
air-dried, rehydrated in an ethanol series, fixed in 1% for-
maldehyde/1 × PBS/50 mM MgCl2 for 7 minutes, washed
in 1 × PBS for 5 minutes, dehydrated in an ethanol series,
and air-dried before hybridization using the ThermoBrite
system.
Spectral Karyotyping (SKY)
SKY was performed using Applied Spectral Imaging, Inc.
(Vista, CA) SkyPaint® probes according to the manufac-
turer's protocol. Image acquisition was accomplished
using the SpectraCube® spectral imaging system (Applied
Spectral Imaging, Inc., Vista, CA) according to the manu-
facturers' instructions.
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Array CGH: microarray comparative genomic hybridiza-
tion; FISH: fluorescence in situ hybridization; SKY: spec-
tral karyotyping; SMC: supernumerary marker
chromosome.
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